Laying the groundwork for new advances with IncuCyte technology

Thanks to our generous donors, SVI is laying the groundwork for new advances in diabetes, cancer and other diseases. On Wednesday 26 March, we came together to celebrate their contributions toward SVI’s purchase of an IncuCyte Live Cell Imaging Platform, a cutting-edge tool that will significantly enhance our research efforts.

This advancement has been made possible by the generosity of the Lions Clubs International Foundation, the Australian Lions International Foundation, the Lions Australia Diabetes Foundation, Tour De Cure and the Bruce Hyams Foundation.

The IncuCyte Live Cell Imaging Platform allows researchers to monitor living cells in real-time, providing unprecedented insights into cellular behaviours and interactions. For diabetes research, this technology is transformative. It enables us to observe the effects of various treatments on insulin-producing beta cells, which are crucial for developing new therapies. By continuously tracking cell health, growth, and responses to interventions, the IncuCyte offers detailed data that can lead to more effective and personalised treatment strategies.

With the support of the Lions community, our researchers are now equipped with the tools needed to make groundbreaking advances in diabetes research. This investment not only accelerates our understanding of the disease but also brings us closer to innovative solutions.